Ursprung des Netzwerks ersten Grades von Michelle Long
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michelle Long
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| HEXIMA LIMITED | Biotechnology | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Radiopharm Theranostics (USA), Inc.
 Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Radiopharm Theranostics (USA), Inc. is an American company founded in 2021 that develops radiopharmaceutical products for diagnostic and therapeutic uses. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Melbourne Business School | College/University | Masters Business Admin Masters Business Admin | |
| RADIOPHARM THERANOSTICS LIMITED | Medical/Nursing Services | Director of Finance/CFO Director/Board Member | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Deakin University | College/University | Undergraduate Degree Masters Business Admin | |
| LaTrobe University | College/University | Doctorate Degree Graduate Degree | |
| RESPIRI LIMITED | Medical Specialties | Corporate Secretary Director/Board Member | |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Triplet Therapeutics, Inc. develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases. The company was founded by Jean-François Formela and Nessan Bermingham is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member | |
| ALLOVIR, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Founder | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
Vascular Pharmaceuticals, Inc.
 Vascular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vascular Pharmaceuticals, Inc. develops and commercializes therapeutics for the treatment of diabetics. It provides new treatment options to individuals living with diabetic complications such as nephropathy. The company was founded by David R. Clemmons and Laura Maile in 2005 and is headquartered in Research Triangle Park, NC. | Pharmaceuticals: Major | Director/Board Member | |
Taylor Collison Ltd.
 Taylor Collison Ltd. Investment Banks/BrokersFinance Taylor Collison Ltd. is an independent brokerage firm headquartered in Adelaide, Australia. The firm was founded in 1988 and offers stockbroking services to private and institutional investors and corporate clients throughout Australia. Their research and corporate focus is on the emerging growth sector of the Australian share market. Taylor Collison uses in-house & external research to establish and maintain diverse & balanced investment portfolios for their clients. | Investment Banks/Brokers | Analyst-Equity | |
| Ottawa University (Kansas) | College/University | Undergraduate Degree | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Founder | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal | |
| Stony Brook University | College/University | Graduate Degree | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
LIB Therapeutics LLC
 LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology LIB Therapeutics LLC is a pharmaceutical company that manufactures medicinal products. The private company is based in Wilmington, DE. The company was founded by Evan A. Stein, August James Troendle. David A. Cory has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member | |
| SYNTARA LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| SIRTEX MEDICAL LIMITED | Miscellaneous Commercial Services | Investor Relations Contact | |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Undergraduate Degree | |
Bio101 Financial Advisory Pty Ltd.
 Bio101 Financial Advisory Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Bio101 Financial Advisory Pty Ltd. provides bookkeeping, strategic financial advice, and administrative services. The private company is based in Camberwell, Australia. The CEO of the Australian company is Cameron Peter Jones. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| TALI DIGITAL LIMITED | Packaged Software | Corporate Secretary | |
| Virginia Polytechnic Institute & State University | College/University | Doctorate Degree | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| CARISMA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Pontifícia Universidade Católica de São Paulo | College/University | Doctorate Degree | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Adelaide | College/University | Doctorate Degree | |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Private Equity Analyst | |
| PHARMAUST LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| NOVA EYE MEDICAL LIMITED | Medical Specialties | Investor Relations Contact | |
| LIMEADE | Packaged Software | Investor Relations Contact | |
| NEUROTECH INTERNATIONAL LIMITED | Medical Specialties | Director/Board Member | |
| INVEX THERAPEUTICS LTD | Biotechnology | Director/Board Member | |
| Liver Foundation of Western Australia | Director/Board Member | ||
Australasian Investor Relations Association
 Australasian Investor Relations Association Miscellaneous Commercial ServicesCommercial Services Australasian Investor Relations Association is an Australian private company located in Sydney. The firm operates as a membership organization for investor relations professionals. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Nemean Group Pty Ltd. | Chief Executive Officer | ||
| MY REWARDS INTERNATIONAL LIMITED | Packaged Software | Director of Finance/CFO | |
Myopharm Ltd.
 Myopharm Ltd. BiotechnologyHealth Technology Myopharm Ltd. develops and produces nutrition specifically for individuals with type 2 diabetes. The Australian company was founded in 2020 and the CEO is Karinza Phoenix. | Biotechnology | Director of Finance/CFO |
Statistik
International
| Australien | 25 |
| Vereinigte Staaten | 25 |
| Brasilien | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Finance | 4 |
| Technology Services | 4 |
Operativ
| Corporate Secretary | 39 |
| Director/Board Member | 34 |
| Director of Finance/CFO | 21 |
| Corporate Officer/Principal | 17 |
| Independent Dir/Board Member | 9 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Phillip Hains | 43 |
| Elizabeth Stoner | 18 |
| Thomas Duthy | 15 |
| Gary Phillips | 8 |
| Michael Baker | 7 |
| Debora Barton | 7 |
| Tim Luscombe | 5 |
| Nicole van der Weerden | 4 |
| Mini Bharathan | 2 |
| Deborah Cooper | 1 |
- Börse
- Insiders
- Michelle Long
- Unternehmensverbindungen
